Daewon Pharmaceutical Co., Ltd. (KRX:003220)
12,540
+40 (0.32%)
At close: Dec 5, 2025
-12.43% (1Y)
| Market Cap | 268.78B |
| Revenue (ttm) | 590.70B |
| Net Income (ttm) | -16.04B |
| Shares Out | 21.43M |
| EPS (ttm) | -748.28 |
| PE Ratio | n/a |
| Forward PE | 76.70 |
| Dividend | 300.00 (2.40%) |
| Ex-Dividend Date | Dec 27, 2024 |
| Volume | 20,385 |
| Average Volume | 43,074 |
| Open | 12,650 |
| Previous Close | 12,500 |
| Day's Range | 12,440 - 12,650 |
| 52-Week Range | 12,250 - 15,910 |
| Beta | 0.21 |
| RSI | 42.87 |
| Earnings Date | Nov 13, 2025 |